✦ LIBER ✦

Characterization and clinical relevance of a new complement-fixing antibod–anti-m8–in patients with primary biliary cirrhosis

✍ Scribed by Paul Weber; Judith Brenner; Ernst Stechemesser; Reinhild Klein; Ulrike Weckenmann; Günter Klöppel; Manfred Kirchhof; Volker Fintelmann; Professor; Dr. Peter A. Berg

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 735 KB
Volume: 6
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.1840060402

No coin nor oath required. For personal study only.

✦ Synopsis

A new complement-fixing antimitochondrial antibody--anti-M8--was detected in patients with primary biliary cirrhosis. Anti-M8 was only found in association with anti-M2, however, not all anti-M2 positive patients had anti-M8. Thus, among 66 anti-M2 positive patients, 29 were also positive for anti-M8, whereas sera from patients who had the complement-fixing anti-M2 and anti-M4 antibodies in parallel always strongly reacted with the M8 antigen. This group was previously described as mixed form. The M8 antigen was isolated either from human liver mitochondria or pig kidney microsomes and could be clearly distinguished from the M4 antigen. In contrast to M4, M8 was trypsin sensitive and banded at sucrose densities from 1.16 to 1.24, while M4 was found at densities from 1.08 to 1.14. Like M4, the M8 antigen also co-purified with outer mitochondrial membranes. Fifty-three patients with primary biliary cirrhosis have been followed over a period of up to 16 years and were classified according to their complement-fixing antimitochondrial antibody profile. At the time of the first diagnosis, 95% of 31 patients being anti-M2 positive, but anti-M8 negative (antimitochondrial antibody Profile I) were in Stage I or II. In contrast, only 61% of 13 patients being anti-M2 and anti-M8 positive (antimitochondrial antibody Profile II) and 44% of 9 patients with anti-M2, anti-M8 and anti-M4 in parallel (antimitochondrial antibody Profile III) belonged to Stage I or II.(ABSTRACT TRUNCATED AT 250 WORDS)

📜 SIMILAR VOLUMES

Reactivities and clinical relevance of a

Reactivities and clinical relevance of antimitochondrial antibodies to four mitochondrial inner membrane proteins in sera of patients with primary biliary cirrhosis

✍ Hideo Ishii; Koji Saifuku; Professor Toshihiko Namihisa 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 362 KB 👁 1 views

Antimitochondrial antibodies are characteristically detected in sera of patients with primary biliary cirrhosis. The antigens to which the antimitochondrial antibodies in primary biliary cirrhosis sera react have been located in the mitochondrial inner membrane. We have reported on four mitochondria

Diagnostic Relevance and Clinical Signif

Diagnostic Relevance and Clinical Significance of the New Enhanced Performance M2 (MIT3) ELISA for the Detection of IgA and IgG Antimitochondrial Antibodies in Primary Biliary Cirrhosis

✍ Stella Gabeta; Gary L. Norman; Christos Liaskos; Panagiotis A. Papamichalis; The 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 211 KB

Fine phenotypic and functional character

Fine phenotypic and functional characterization of effector cluster of differentiation 8 positive T cells in human patients with primary biliary cirrhosis

✍ Masanobu Tsuda; Yoko M. Ambrosini; Weici Zhang; Guo-Xiang Yang; Yugo Ando; Guang 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 440 KB 👁 1 views

In primary biliary cirrhosis (PBC), patients develop a multilineage response to a highly restricted peptide of the E2 component of pyruvate dehydrogenase (PDC-E2) involving autoantibody and autoreactive cluster of differentiation (CD)4 1 and CD8 1 T-cell responses. Recent data from murine models hav